What Zealthy does

Zealthy is a private, direct-to-consumer telehealth platform founded in 2023 and headquartered in New York, NY (with Miami Beach listed as an additional operating location) that delivers virtual care across weight loss, primary care, mental health, dermatology, hair loss, erectile dysfunction, birth control, PrEP, and enclomiphene. The company operates a fully digital intake and care-coordination stack — patients complete online health assessments, are matched with licensed U.S. providers, receive asynchronous messaging support, and obtain prescriptions through partner sterile compounding and mail-order pharmacies with home delivery. Its flagship offering is a weight-loss program built around GLP-1 medications (semaglutide and tirzepatide, both branded and compounded), supported by a coaching layer with dedicated coaches, nutrition planning, and accountability check-ins. A differentiated branded sub-line, "Zealthy Hardies," markets proprietary sublingual ED formulations combining sildenafil, tadalafil, and/or oxytocin.

The business model is a recurring subscription stack. The core weight-loss membership is priced at $39 first month and $135/month thereafter; ED subscriptions start at $9/dose on 1–5 month supply plans; dermatology consultations are $20; and compounded GLP-1 medications are offered from approximately $151–$216/month, with insurance coordination potentially reducing branded GLP-1 costs to ~$25/month and HSA/FSA cards accepted. Go-to-market is product-led and PLG-style: self-serve sign-up on the website and free iOS/Android apps, supplemented by SEO, content marketing, social media (Facebook, Instagram, Reddit, Pinterest, TikTok), earned media, and patient testimonials. As of November 2024, Zealthy reported 40,000+ active members across 28 U.S. states with stated intent to reach all 50; headcount is 11–50, and no institutional funding rounds have been disclosed — the company appears to have been built largely without external equity capital.

Material strategic context for any analytical reader: Zealthy is led by CEO Kyle Robertson, who previously founded Cerebral (subsequently fined $2.9 million for unauthorized distribution of controlled substances). In April 2026, the U.S. Department of Justice filed a motion seeking an immediate asset freeze and receivership over Zealthy and Robertson, alleging fraudulent prescribing practices involving unlicensed foreign call-center contractors and misuse of physicians' credentials without supervision; a parallel TCPA class action has also been filed. The company's June 2026 platform and insurance-coordination launches indicate continued operating activity, but the DOJ matter represents an existential regulatory overhang on the operating model.

Name

Zealthy

Legal name

Zealthy, Inc.

Website

https://getzealthy.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

11–50 employees

Short description

Zealthy is a private, direct-to-consumer telehealth platform offering subscription-based virtual care across weight loss (GLP-1s + coaching), mental health, primary care, dermatology, hair loss, ED, and birth control to individual consumers in 28 U.S. states.

Ownership category

akta.pro rank

Product category

Telehealth / Virtual Healthcare

NAICS

Offices of Physicians (6211)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Primary Care & General Medicine Virtual Care (HLALAAAA)

akta.pro secondary industry

Endocrinology & Diabetes Telemedicine Platforms (HLALAGAD)

Keywords

• Telehealth services
• Weight loss treatment
• Virtual primary care
• Online prescription care
• Dermatology consultations

Headquarters

HQ city

Miami Beach

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Weight Loss Membership: Monthly subscription membership for weight loss program including provider consultations, prescription management, coaching, and ongoing care. First month promotional pricing at $39, then $135/month. Membership is recurring and auto-billed monthly.
2. GLP-1 Medications: Revenue from GLP-1 weight loss medications including branded (Wegovy, Zepbound, Ozempic, Mounjaro) and compounded versions (semaglutide, tirzepatide). Medication costs billed separately from membership. Insurance coordination team works to maximize coverage.
3. Erectile Dysfunction Treatments: Subscription plans for ED medications including Zealthy Hardies (sublingual formulations) and traditional ED medications. Hardies available from $9/dose on subscription plans ranging from 1-5 month supplies.
4. Dermatology Services: Virtual dermatology consultations priced at $20, with prescription treatments for acne, hyperpigmentation, rosacea, and other skin conditions. Treatments shipped to patients with free shipping on 3-month supplies.
5. Other Healthcare Services: Additional services including primary care consultations, mental health treatments for anxiety/depression, birth control prescriptions, hair loss treatments, sleep treatments, PrEP, and enclomiphene. Most services offered with or without insurance.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Zealthy is a direct-to-consumer telehealth platform that delivers virtual healthcare across weight loss (GLP-1 medications with coaching), primary care, mental health, dermatology, hair loss, erectile dysfunction, and birth control. Patients complete online health assessments, are connected with licensed providers — typically in about 15 minutes — receive prescriptions, and obtain medications delivered to their homes, supported by unlimited messaging and follow-up care coordination.

Differentiator

Problem solved

Functional benefit

Brands

• Zealthy Hardies: Sublingual erectile dysfunction treatment combining sildenafil, tadalafil, and/or oxytocin for fast-acting ED medication.

Products and services

• Weight Loss Program A subscription-based virtual weight loss program that combines GLP-1 medications (e.g., semaglutide, tirzepatide) with personalized coaching, AI-powered meal planning, and exercise tracking for adults seeking prescription-assisted weight loss. Pricing tiers start at $99/month for the first month and $249/month ongoing, with insurance coordination available.
• Virtual Primary Care Online primary care consultations for non-urgent health concerns, with insurance-accepted pricing in select states (typically $0 with insurance coverage or $75 cash-pay per visit). Targets adults seeking convenient access to a clinician for routine care.
• Mental Health Treatment (Anxiety & Depression)
• Skincare / Dermatology Treatment
• Erectile Dysfunction Treatment (including Zealthy Hardies)
• Hair Loss Treatment
• Birth Control
• Enclomiphene Treatment

Quantifiable outcome

• Patients typically lose 15-20% of body weight over a year when combining GLP-1 medication with lifestyle changes
• +4 more outcomes

Named customers12 records

Segments6 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature4 records

Partnerships

One partnership is on record.

• Eli Lilly and CompanyminorOthersManufacturer of Zepbound (tirzepatide) and Mounjaro, which are FDA-approved GLP-1 medications prescribed through Zealthy's platform for weight loss and diabetes treatment.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Hims & Hers Health: DTC telehealth platform offering weight loss, ED, hair loss, skincare, mental health and primary care via subscriptions. Directly mirrors Zealthy's multi-vertical DTC model with overlapping customer base and subscription pricing structure.
• Ro: DTC telehealth platform covering weight management (including GLP-1s), men's sexual health, skincare, and primary care. Directly competes in the same use cases and customer segments, with comparable branded product positioning.
• K Health: DTC virtual primary care platform using AI triage and affordable subscription pricing. Directly comparable on consumer-friendly primary care positioning and horizontal expansion into adjacent conditions.
• PlushCare: DTC virtual care offering primary, mental health, weight management and chronic condition treatment with insurance-accepting model. Comparable go-to-market as an insured-accepting DTC telehealth competitor.

Broad incumbents

• Teladoc Health: Large incumbent virtual care platform spanning primary care, mental health, chronic condition management and dermatology. Overlaps with Zealthy's broad virtual-care catalog but serves primarily enterprise/payer contracts alongside its DTC offerings.
• Amwell: Established telehealth infrastructure provider offering virtual primary, urgent, and behavioral care visits through health systems, insurers and employers. Comparable in modality (virtual visits) and clinical scope but primarily B2B distribution.

Emerging players

• Noom: Weight loss program that has expanded into GLP-1 medication access via telehealth. Targeted competitor within Zealthy's flagship weight-loss use case with comparable subscription pricing and coaching overlay.
• Calibrate: DTC metabolic health/weight loss program combining GLP-1 prescriptions with coaching. Overlaps in the same weight-loss-with-coaching positioning though narrower in scope than Zealthy's full catalog.
• Done (Done.Global): Subscription-based telehealth for ADHD and adjacent conditions. Comparable DTC subscription telehealth model with similar regulatory scrutiny on controlled-prescribing practices.

Others

• Cerebral: Prior mental-health and weight-management telehealth venture founded by Zealthy's CEO Kyle Robertson. Relevant comparison given shared leadership, overlapping prescribing model, and Cerebral's prior $2.9M controlled-substance enforcement action.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/getzealthy
• Instagraminstagram.com/tryzealthy
• Pinterestin.pinterest.com/getzealthy
• TikToktiktok.com/@getzealthy

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zealthy